CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Grant or award Senior Vice President, Devices acquired 15,808 shares (grant or award)
- 4 Grant or award President and CEO acquired 44,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 24,193 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 8,333 shares (grant or award)
- 4 Grant or award Director acquired 111,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 41,666 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Open-market buy President and CEO bought 500 shares at an average $3.03 ($1,513)
- 4 Open-market buy President and CEO bought 500 shares at $3.29 ($1,645)
- 4 Open-market buy President and CEO bought 500 shares at $3.52 ($1,760)
- 4 Open-market buy President and CEO bought 1,000 shares at $3.36 ($3,360)
- 4 Open-market buy President and CEO bought 2,750 shares at $0.37 ($1,013)
- 4 Open-market buy President and CEO bought 500 shares at $0.39 ($195)
- 4 Open-market buy President and CEO bought 108,108 shares at $0.46 ($50,000)
Page 5 of 23 · 442 filings